These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2007401)

  • 1. N-Butyl-N-methyl-4-nitrophenyl carbamate as a specific active site titrator of bile-salt-dependent lipases.
    Fourneron JD; Abouakil N; Chaillan C; Lombardo D
    Eur J Biochem; 1991 Mar; 196(2):295-303. PubMed ID: 2007401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
    Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
    Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p-Nitrophenyl and cholesteryl-N-alkyl carbamates as inhibitors of cholesterol esterase.
    Hosie L; Sutton LD; Quinn DM
    J Biol Chem; 1987 Jan; 262(1):260-4. PubMed ID: 3793726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-reactivity probes for active site shapes of cholesterol esterase by carbamate inhibitors.
    Lin G; Shieh CT; Tsai YC; Hwang CI; Lu CP; Chen GH
    Biochim Biophys Acta; 1999 May; 1431(2):500-11. PubMed ID: 10350625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition by cholesterol esterase of active site ligands: structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover.
    Feaster SR; Lee K; Baker N; Hui DY; Quinn DM
    Biochemistry; 1996 Dec; 35(51):16723-34. PubMed ID: 8988009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity relationships for the pre-steady-state inhibition of cholesterol esterase by 4-nitrophenyl-N-substituted carbamates.
    Lin G; Liao WC; Chiou SY
    Bioorg Med Chem; 2000 Nov; 8(11):2601-7. PubMed ID: 11092545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human milk bile-salt-dependent lipase by boronic acids. Implication to the bile salts activator effect.
    Abouakil N; Lombardo D
    Biochim Biophys Acta; 1989 Aug; 1004(2):215-20. PubMed ID: 2752019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of lipoprotein lipase with p-nitrophenyl N-alkylcarbamates: kinetics, mechanism, and analogy to the acylenzyme mechanism.
    Shin HC; Quinn DM
    Biochemistry; 1992 Jan; 31(3):811-8. PubMed ID: 1731939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butyl carbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase.
    Lin G; Lee YR; Liu YC; Wu YG
    Chem Res Toxicol; 2005 Jul; 18(7):1124-31. PubMed ID: 16022504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomeric inhibitors of cholesterol esterase and acetylcholinesterase.
    Lin G; Tsai YC; Liu HC; Liao WC; Chang CH
    Biochim Biophys Acta; 1998 Oct; 1388(1):161-74. PubMed ID: 9774723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic bile salt dependent lipase from cod (Gadus morhua): purification and properties.
    Gjellesvik DR; Lombardo D; Walther BT
    Biochim Biophys Acta; 1992 Mar; 1124(2):123-34. PubMed ID: 1543734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the catalytic mechanism of staphylococcal lipases using carbamate substrates: chain length selectivity, interfacial activation, and cofactor dependence.
    Simons JW; Boots JW; Kats MP; Slotboom AJ; Egmond MR; Verheij HM
    Biochemistry; 1997 Nov; 36(47):14539-50. PubMed ID: 9398172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A carbamate-based approach to primaquine prodrugs: antimalarial activity, chemical stability and enzymatic activation.
    Mata G; do Rosário VE; Iley J; Constantino L; Moreira R
    Bioorg Med Chem; 2012 Jan; 20(2):886-92. PubMed ID: 22189276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cholesterol esterases. 3. Kinetic characterization of cholesterol ester resynthesis by the pancreatic cholesterol esterases.
    Kyger EM; Riley DJ; Spilburg CA; Lange LG
    Biochemistry; 1990 Apr; 29(16):3853-8. PubMed ID: 2354156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digestive lipases of the newborn ferret: compensatory role of milk bile salt-dependent lipase.
    Sbarra V; Mas E; Henderson TR; Hamosh M; Lombardo D; Hamosh P
    Pediatr Res; 1996 Aug; 40(2):263-8. PubMed ID: 8827775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin.
    Borgström B
    Biochim Biophys Acta; 1988 Oct; 962(3):308-16. PubMed ID: 3167082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationships for the pre-steady state of Pseudomonas species lipase inhibitions by p-nirophenyl-N-substituted carbamates.
    Lin G; Liao WC; Ku ZH
    Protein J; 2005 May; 24(4):201-7. PubMed ID: 16283542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of human milk bile salt activated lipase.
    Baba T; Downs D; Jackson KW; Tang J; Wang CS
    Biochemistry; 1991 Jan; 30(2):500-10. PubMed ID: 1988041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as conformationally constrained inhibitors of cholesterol esterase.
    Lin MC; Lin GZ; Hwang CI; Jian SY; Lin J; Shen YF; Lin G
    Protein Sci; 2012 Sep; 21(9):1344-57. PubMed ID: 22811279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of bovine pancreatic cholesterol esterase at 1.6 A: novel structural features involved in lipase activation.
    Chen JC; Miercke LJ; Krucinski J; Starr JR; Saenz G; Wang X; Spilburg CA; Lange LG; Ellsworth JL; Stroud RM
    Biochemistry; 1998 Apr; 37(15):5107-17. PubMed ID: 9548741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.